ANGO — ANGIODYNAMICS INC

Nasdaq · Health Care · Health Care Equipment & Supplies · CIK 1275187 ·
Last close
$14.79
Market Cap
$611.31M
52W High
$15.20
52W Low
$10.65
ADV30
529,766
Next earnings
AngioDynamics, Inc., a medical technology company, designs, manufactures, and sells products for the treatment of cardiovascular disease and cancer diagnoses in the United States and internationally. The company operates through Med Tech and Med Device segments. It offers Auryon Atherectomy system that delivers an optimized wavelength and short pulse width to remove lesions while preserving vessel wall endothelium. The company's thrombus management portfolio includes AlphaVac mechanical thrombectomy system, an emergent mechanical aspiration device that eliminates the need for perfusionist support; thrombolytic catheters that are used to deliver thrombolytic agents, which are drugs to dissolve blood clots in hemodialysis access grafts, arteries, veins, and surgical bypass grafts; and AngioVac venous drainage cannula and extracorporeal circuit for use in extracorporeal circulatory support procedures for periods of up to six hours, as well as with other manufacturers' off-the-shelf pump, filter, and reinfusion cannula facilitate venous drainage. It also offers NanoKnife IRE Ablation System, an alternative to traditional thermal ablation for the surgical ablation of soft tissue; and peripheral products, which include angiographic catheters, guidewires, drainage catheters, and micropuncture kits for use in invasive procedures. In addition, the company provides total abscession drainage catheters for multi-purpose/general and biliary configurations, and nephrostomy options; mini stick MAX Coaxial microintroducer kits and micro-introducer kits; ports; VenaCure EVLT system that are used in endovascular laser procedures to treat superficial venous disease; and Solero Microwave Tissue Ablation System includes solero microwave generator and the solero MW applicators. AngioDynamics, Inc. was founded in 1988 and is headquartered in Latham, New York.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
May 2026
Feb 2026 78,423,000 41,479,000 -6,429,000 -8,084,000 260,678,000 37,810,000 87,321,000
Nov 2025 79,433,000 44,783,000 -2,490,000 -6,350,000 269,681,000 41,638,000 93,348,000
Aug 2025 75,711,000 41,857,000 -7,898,000 -10,903,000 265,642,000 38,762,000 86,787,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$3,089,000
Investing CF
$-5,949,000
Financing CF
$564,000
CapEx
$-2,581,000
Dividends Paid
Buybacks
$0
EPS Diluted TTM
$-0.87
As of
2026-07-19

Balance + Analyst (yfinance extras)

Retained Earnings
$-465,939,000
Inventory
$52,436,000
Receivables
$48,514,000
ST Investments
EBIT TTM
$-22,329,000
Pretax Income TTM
$-36,300,000
Interest Exp TTM
Analysts
4

Yahoo Snapshot (yfinance, live)

Total Revenue
$320,174,016
EBITDA
$188,000
Free Cash Flow
$21,770,250
Enterprise Value
$567,571,392
Total Cash
$53,864,000
Total Debt
$10,956,000
Shares Out
41,332,389
Trailing EPS
$-0.88
Book Value
$4.10
ROE
-20.8%
ROA
-5.1%
Div Yield

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
May 2026 320,174,000 -22,329,000 -36,742,000 267,163,000 96,338,000 3,089,000
May 2025 292,498,000 -24,062,000 -33,993,000 280,144,000 97,174,000 -10,128,000
May 2024 303,914,000 -33,844,000 -184,349,000 317,671,000 112,085,000 -28,158,000
May 2023 338,752,000 -18,679,000 -52,442,000 532,637,000 154,341,000 78,000

TTM Snapshot

Revenues TTM
$297,489,000
NetIncome TTM
$-210,369,000
OpCashFlow TTM
$0
Assets (Latest)
$280,144,000
Forward EPS
$-0.04

Peers — same industry

TickerNameMarket CapLastDaily %
BWAY Brainsway Ltd. $611.20M $15.23
BRSYF Brainsway Ltd. $607.19M $15.13
MDXG MIMEDX GROUP, INC. $601.99M $4.13
TCMD TACTILE SYSTEMS TECHNOLOGY INC $635.41M $28.17
BBNX Beta Bionics, Inc. $577.22M $12.83

News headlines (Yahoo Finance, 1h cache)

AngioDynamics to Participate in Upcoming Investor Conferences
2026-07-28 12:30 · Yahoo
AngioDynamics (ANGO) Q4 2026 Earnings Call Transcript
2026-07-21 19:47 · Yahoo
AngioDynamics Q4 Earnings Beat Estimates, Gross Margin Expands
2026-07-15 14:29 · Yahoo
AngioDynamics, Inc. Q4 2026 Earnings Call Summary
2026-07-15 12:30 · Yahoo
AngioDynamics Inc (ANGO) Q4 2026 Earnings Call Highlights: Strong Revenue Growth Amidst Challenges
2026-07-14 19:00 · Yahoo
AngioDynamics Q4 Earnings Call Highlights
2026-07-14 13:03 · Yahoo
AngioDynamics (ANGO) Reports Q4 Loss, Beats Revenue Estimates
2026-07-14 11:15 · Yahoo
AngioDynamics Tops Revenue Forecasts and Raises Sales Outlook for Fiscal 2027 (ANGO)
2026-07-14 10:49 · Yahoo
AngioDynamics: Fiscal Q4 Earnings Snapshot
2026-07-14 10:18 · Yahoo
AngioDynamics Reports Record Fiscal Year 2026 Fourth Quarter and Full Year Financial Results; Continued Execution Drives Med Tech Growth and Full-Year Profitability
2026-07-14 10:00 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.